Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 504, pseudogene (RNU6-504P) is a pseudogene derived from U6 small nuclear RNA (U6 snRNA), a key component of the spliceosome complex responsible for pre-mRNA splicing in eukaryotes[3][5]. Pseudogenes are typically nonfunctional segments of DNA that resemble functional genes but have lost their protein-coding or RNA-producing ability, often due to mutations or truncation[5]. U6 snRNA pseudogenes, such as RNU6-504P, are generated through retrotransposition mechanisms involving LINE (Long Interspersed Nuclear Element) activity, where RNA intermediates of the parent U6 gene are reverse transcribed and inserted into other genomic locations without necessary regulatory sequences, preventing them from fulfilling normal biological roles[5]. These U6-derived pseudogenes do not encode proteins, nor do they act as receptors, enzymes, or therapeutic targets[5]. U6 snRNA itself is essential for splicing, but its pseudogenes—including RNU6-504P—serve primarily as genomic markers of retrotransposition dynamics and have no known direct functional, therapeutic, or biomarker relevance[5]. Summary: RNU6-504P is a non-functional, processed pseudogene of U6 small nuclear RNA, with no known biological activity, therapeutic relevance, or disease association. It is not considered a drug target or biomarker, but rather a molecular fossil reflecting historical retrotranspositional events in the genome[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 504, pseudogene (RNU6-504P).